Evidence map›Paper›PMID 39945827›Full record

Observational studyRheumatology international2025

Impact of systemic lupus erythematosus on the reproductive health of women before and after disease onset: an observational study.

S Chandrashekara, Padmanabha Shenoy, Uma Kumar, Sapan Pandya, Alakendu Ghosh, Apurva Khare, Rajkiran Dudam, Rudra Prosad Goswami

Abstract readObservational StudyMulticenter Study
PubMed Publisher
In one paragraph

Observational study in Rheumatology international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S ChandrashekaraChanRe Rheumatology and Immunology Center and Research, Bengaluru, India. chandrashekara_s@yahoo.com.ORCID 0000-0003-2661-9840
Padmanabha ShenoyCentre for Arthritis & Rheumatism Excellence (CARE), Cochin, Kerala, India.
Uma KumarDepartment of Rheumatology, All India Institute of Medical Science, New Delhi, India.
Sapan PandyaRheumatic Disease Clinic, 4th floor Vedanta Institute of Medical Science, Commerce College Road, Navrangpura, Ahmedabad, Gujarat, 380009, India.
Alakendu GhoshClinical Immunology & Rheumatology Institute of Postgraduate Medical Education and Research, Kolkata, 700020, India.
Apurva KhareDepartment of General Medicine, LN Medical College and Research Center, Kolar road, Bhopal, Madhya Pradesh, 462042, India.
Rajkiran DudamHRC Hospital, Prakash Nagar, Begumpet, Hyderabad, India.
Rudra Prosad GoswamiDepartment of Rheumatology, AIIMS, New Delhi, India.

Funding

Novartis India Novartis India
6 · The paper itself

Abstract

Systemic lupus erythematosus (SLE) is a chronic autoimmune disorder that can significantly affect reproductive health. This study aims to assess reproductive health metrics among SLE patients in Indian settings to compare fertility rates and the impact of the disease on pregnancy with data from the general population. The independent, prospective, multicenter, observational study collected data from SLE patients at seven centres in India through a database created by the Indian Rheumatology Association. Data were gathered using structured proformas validated by experts. The final analysis included women aged > 15 years (total cohort), after excluding male subjects and those with inadequate data. Participants were categorized into married and unmarried cohorts, and various reproductive health metrics were analyzed pre- and post-disease. The total cohort included 631 subjects with an average age at recruitment of 36.46 ± 12.31 years, and mean age at menarche of 13.74 ± 1.44 years. The total cohort had an average of 1.8 pregnancies per woman, with an abortion rate of 0.35. The married cohort showed a pregnancy wastage ratio of 201.43. The cumulative fertility rate noted for the married cohort was 1.40, while for the total cohort was 1.04. Significant differences in pregnancy outcomes were observed before and after the onset of SLE, with pregnancies declining from 703 to 136 (P < 0.0001). A significant increase in pregnancy complications, including pregnancy-induced hypertension, small for gestational age, and pre-eclampsia, was noted before and after disease onset (P < 0.0001). Central nervous system and skin involvement also became more prevalent post-disease (P = 0.046 and P = 0.040, respectively). The study highlights the significant impact of SLE on pregnancy, both before and after disease onset, noting reduced pregnancies and live births, along with increased rates of pregnancy loss, stillbirths, and abortions. Complications such as hypertension and pre-eclampsia were more common after disease onset. These findings emphasize the need for targeted healthcare strategies and collaborative efforts to improve reproductive outcomes in patients with SLE.

Indexed as

FertilityLupus Erythematosus, SystemicPregnancy ComplicationsReproductive HealthAbortion, SpontaneousAdolescentAdultFemaleHumansIndiaMiddle AgedPregnancyPregnancy OutcomeProspective StudiesYoung AdultAutoimmune diseasesFertility ratesPregnancy complicationsPregnancy lossReproductive healthSystemic lupus erythematosus

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.